Outcomes of patients with secondary central nervous system lymphoma treated with chimeric antigen receptor T-cell therapy: A CIBMTR analysis
Outcomes of patients with secondary central nervous system lymphoma treated with chimeric antigen receptor T-cell therapy: A CIBMTR analysis

Outcomes of patients with secondary central nervous system lymphoma treated with chimeric antigen receptor T-cell therapy: A CIBMTR analysis

Br J Haematol. 2024 May 26. doi: 10.1111/bjh.19569. Online ahead of print.

NO ABSTRACT

PMID:38797526 | DOI:10.1111/bjh.19569